Rare lephants
Screener

Bright Minds Biosciences Inc.

DRUG ·Healthcare, Drug Manufacturers - General, United States
Valuation › Two-Stage DCF

Two-Stage DCF isn’t available yet

Not enough filings data to compute a starting per-share figure for DRUG (needs operating cash flow/capital expenditures, or diluted EPS as a fallback, for at least one recent quarter or fiscal year).